Getting back to the Board,
Brian Thomas is listed as a non-executive director however that is incorrect because he is an emplpoyee of the Company(he's the Technical Director). Therefore he is an executive director. His $240,000 salary is paid by the Company for his Technical Director position.
The remaining two Directors are not employees of LNR and therefore are non-executive directors and are remunerated out of the Non-Executive Directors’ fee pool.
Extract from Annual Report:
Non-Executive Directors’ fees are determined within the Non-Executive Directors’ fee pool limit, which is
periodically recommended for approval by shareholders. The pool currently stands at $300,000 per annum for Non Executive Directors has approved at the Company’s Annual General Meeting on 26 November 2019
.........and David Francis & Peter Swiridiuk cash remuneration adds up to $299,996. They are milking that pool for what it's worth without an at-risk performance based component. They can use all of it irrespective of how many non-executive directors are on teh Board.
When shareholders agreed to that pool, they should have stated that it was to be prorata according to the number of non-executive directors. Under current arrangement if there was only one non-executive director that person could hog the whole lot! I don't understand why Peter Swiridiuk is remunerated $239,996 for the year as a non-executive director.David Frances gets $60,000.
I think this is rather unprofessional and the pool needs to be either scrapped or prorata with a max figure for any individual.
- Forums
- ASX - By Stock
- LNR
- Ann: Tenement Application Adjacent to Significant Drill Results
LNR
lanthanein resources ltd
Add to My Watchlist
0.00%
!
0.1¢

Ann: Tenement Application Adjacent to Significant Drill Results, page-55
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.810M |
Open | High | Low | Value | Volume |
0.1¢ | 0.1¢ | 0.1¢ | $90 | 90K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 38348663 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 64584002 | 54 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 38048663 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 60584002 | 52 |
0.003 | 34188467 | 18 |
0.004 | 7920991 | 12 |
0.005 | 7508000 | 9 |
0.006 | 50000 | 1 |
Last trade - 13.23pm 27/06/2025 (20 minute delay) ? |
Featured News
LNR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online